Skip to main navigation
Skip to search
Skip to main content
University of Birmingham Home
Help & FAQ
Home
Research output
Profiles
Research units
Projects
Activities
Datasets
Equipment
Prizes
Press/Media
Search by expertise, name or affiliation
Landiolol for managing atrial fibrillation in intensive care.
S Rehberg
, M Joannidis
,
T Whitehouse
, A Morelli
Inflammation and Ageing
Research output
:
Contribution to journal
›
Article
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Landiolol for managing atrial fibrillation in intensive care.'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Atrial Fibrillation
100%
Intensive Care
100%
Landiolol
100%
Intensive Care Patients
40%
Heart Rate Control
40%
Japan
20%
Patient-centered
20%
Catecholamines
20%
Risk Reduction
20%
Clinical Experience
20%
Beta-blockers
20%
Emergency Setting
20%
Critical Care Unit
20%
Elevated Heart Rate
20%
Ultrashort
20%
Arterial Hypotension
20%
Negative Inotropic Effect
20%
Medicine and Dentistry
Atrial Fibrillation
100%
Intensive Care
100%
Landiolol
100%
Emergency Care
20%
Hypotension
20%
Catecholamine
20%
Beta Adrenergic Receptor Blocking Agent
20%
Inotropism
20%
Nursing and Health Professions
Intensive Care
100%
Atrial Fibrillation
100%
Landiolol
100%
Emergency Care
20%
Beta Adrenergic Receptor Blocking Agent
20%
Catecholamine
20%
Hypotension
20%
Pharmacology, Toxicology and Pharmaceutical Science
Atrial Fibrillation
100%
Landiolol
100%
Beta Adrenergic Receptor Blocking Agent
20%
Catecholamine
20%
Hypotension
20%